NCT05938387
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05938387
Title Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors CureVac
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | DEU | BEL

Facility Status City State Zip Country Details
Universitair Ziekenhuis Brussel - PPDS Brussels Belgium Details
CHU de Liège Liège Belgium Details
Universitätsklinikum Freiburg Freiburg im Breisgau Baden-Wurttemberg Germany Details
University Clinic Heidelberg Heidelberg Baden-Wurttemberg Germany Details
Universitätsmedizin Mannheim Mannheim Baden-Wurttemberg Germany Details
Universitätsklinikum Tübingen Tübingen Baden-Wurttemberg Germany Details
University Clinic Regensburg Regensburg Bavaria Germany Details
Universitätsklinikum Frankfurt Frankfurt am Main Hesse Germany Details
Universitätsklinikum Bonn Bonn North Rhine-Westphalia Germany Details
University Hospital Essen Essen North Rhine-Westphalia Germany Details
Universitatsklinikum Leipzig Leipzig Saxony Germany Details
Neurosurgical Clinic at the LMU Munich München Germany Details
Erasmusmc Cancer institute Rotterdam South Holland Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field